Literature DB >> 3618286

Psychiatric morbidity in acromegaly.

R T Abed, J Clark, M H Elbadawy, M J Cliffe.   

Abstract

Previous reports on psychiatric morbidity in acromegaly have been unsystematic. This study examined 51 acromegalic patients for psychiatric morbidity using the General Health Questionnaire and a standard psychiatric interview, the Present State Examination. Although psychiatric morbidity was higher in the female than the male acromegalics, the study showed no increase in psychiatric morbidity in general, nor an increased incidence of depression, in comparison with general population and patient samples. No relationship was found between growth hormone levels and psychiatric morbidity. The results raise the question whether acromegalic patients show lower psychiatric morbidity than expected from patients with such an illness. The data suggest that previous reports of depression in acromegalic patients examplify the simple coincidence of a likely and an unlikely condition.

Entities:  

Mesh:

Year:  1987        PMID: 3618286     DOI: 10.1111/j.1600-0447.1987.tb02848.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  5 in total

1.  Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy.

Authors:  H Alibas; K Uluc; P Kahraman Koytak; M M Uygur; N Tuncer; T Tanridag; D Gogas Yavuz
Journal:  J Endocrinol Invest       Date:  2017-06-28       Impact factor: 4.256

Review 2.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

3.  Psychosocial morbidity in acromegaly: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Ramma Malhotra
Journal:  Endocrine       Date:  2008-10-25       Impact factor: 3.633

Review 4.  Self image and quality of life in acromegaly.

Authors:  Paola Pantanetti; Nicoletta Sonino; Giorgio Arnaldi; Marco Boscaro
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

5.  Depression in acromegaly treated with escitalopram and cognitive therapy.

Authors:  Avinash De Sousa
Journal:  Indian J Psychol Med       Date:  2009-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.